These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22393064)

  • 1. Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site-specific binding.
    Ono K; Li L; Takamura Y; Yoshiike Y; Zhu L; Han F; Mao X; Ikeda T; Takasaki J; Nishijo H; Takashima A; Teplow DB; Zagorski MG; Yamada M
    J Biol Chem; 2012 Apr; 287(18):14631-43. PubMed ID: 22393064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.
    Takahashi R; Ono K; Takamura Y; Mizuguchi M; Ikeda T; Nishijo H; Yamada M
    J Neurochem; 2015 Sep; 134(5):943-55. PubMed ID: 26016728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway.
    Hamaguchi T; Ono K; Murase A; Yamada M
    Am J Pathol; 2009 Dec; 175(6):2557-65. PubMed ID: 19893028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral Amyloidosis.
    Yamada M; Ono K; Hamaguchi T; Noguchi-Shinohara M
    Adv Exp Med Biol; 2015; 863():79-94. PubMed ID: 26092627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosmarinic acid suppresses Alzheimer's disease development by reducing amyloid β aggregation by increasing monoamine secretion.
    Hase T; Shishido S; Yamamoto S; Yamashita R; Nukima H; Taira S; Toyoda T; Abe K; Hamaguchi T; Ono K; Noguchi-Shinohara M; Yamada M; Kobayashi S
    Sci Rep; 2019 Jun; 9(1):8711. PubMed ID: 31213631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
    Taguchi R; Hatayama K; Takahashi T; Hayashi T; Sato Y; Sato D; Ohta K; Nakano H; Seki C; Endo Y; Tokuraku K; Uwai K
    Eur J Med Chem; 2017 Sep; 138():1066-1075. PubMed ID: 28759879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary Intake of Rosmarinic Acid Increases Serum Inhibitory Activity in Amyloid A Aggregation and Suppresses Deposition in the Organs of Mice.
    Lin X; Watanabe K; Kuragano M; Kurotaki Y; Nakanishi U; Tokuraku K
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosmarinic acid attenuates β-amyloid-induced oxidative stress via Akt/GSK-3β/Fyn-mediated Nrf2 activation in PC12 cells.
    Rong H; Liang Y; Niu Y
    Free Radic Biol Med; 2018 May; 120():114-123. PubMed ID: 29555592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal.
    Pitt J; Roth W; Lacor P; Smith AB; Blankenship M; Velasco P; De Felice F; Breslin P; Klein WL
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):189-97. PubMed ID: 19631677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of intraneuronal β-amyloid 42 peptides is associated with early changes in microtubule-associated protein 2 in neurites and synapses.
    Takahashi RH; Capetillo-Zarate E; Lin MT; Milner TA; Gouras GK
    PLoS One; 2013; 8(1):e51965. PubMed ID: 23372648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Alzheimer's disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers.
    Ochiishi T; Kaku M; Kiyosue K; Doi M; Urabe T; Hattori N; Shimura H; Ebihara T
    Sci Rep; 2019 Nov; 9(1):17368. PubMed ID: 31757975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural compounds against Alzheimer's disease: molecular recognition of Aβ1-42 peptide by Salvia sclareoides extract and its major component, rosmarinic acid, as investigated by NMR.
    Airoldi C; Sironi E; Dias C; Marcelo F; Martins A; Rauter AP; Nicotra F; Jimenez-Barbero J
    Chem Asian J; 2013 Mar; 8(3):596-602. PubMed ID: 23303581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
    Bate C; Williams A
    Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of rosmarinic acid on amyloid beta 42-induced echoic memory decline: Implication of oxidative stress and cholinergic impairment.
    Kantar Gok D; Hidisoglu E; Ocak GA; Er H; Acun AD; Yargıcoglu P
    Neurochem Int; 2018 Sep; 118():1-13. PubMed ID: 29655652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
    J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spearmint Extract Containing Rosmarinic Acid Suppresses Amyloid Fibril Formation of Proteins Associated with Dementia.
    Ogawa K; Ishii A; Shindo A; Hongo K; Mizobata T; Sogon T; Kawata Y
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33202830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosmarinic acid- and curcumin-loaded polyacrylamide-cardiolipin-poly(lactide-co-glycolide) nanoparticles with conjugated 83-14 monoclonal antibody to protect β-amyloid-insulted neurons.
    Kuo YC; Tsai HC
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():445-457. PubMed ID: 30033276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. {beta}-Amyloid impairs AMPA receptor trafficking and function by reducing Ca2+/calmodulin-dependent protein kinase II synaptic distribution.
    Gu Z; Liu W; Yan Z
    J Biol Chem; 2009 Apr; 284(16):10639-49. PubMed ID: 19240035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
    Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
    Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity.
    Guivernau B; Bonet J; Valls-Comamala V; Bosch-Morató M; Godoy JA; Inestrosa NC; Perálvarez-Marín A; Fernández-Busquets X; Andreu D; Oliva B; Muñoz FJ
    J Neurosci; 2016 Nov; 36(46):11693-11703. PubMed ID: 27852777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.